Novel role of c-jun N-terminal kinase in regulating the initiation of cap-dependent translation

International Journal of Oncology

Volumn 40, Issue 2, 2012, Pages 577-582

  Patel, Manish R ^a   Sadiq, Ahad A ^a   Jay Dixon, Joe ^a   Jirakulaporn, Tanawat ^a   Jacobson, Blake A ^a   Farassati, Faris ^b   Bitterman, Peter B ^b,c   Kratzke, Robert A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c PACC Medicine   (United States)

Author keywords

4E BP1; c jun N terminal kinase; Cap dependent translation; eIF4E; Non small cell lung cancer

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; INITIATION FACTOR 4E BINDING PROTEIN 1; INITIATION FACTOR 4F; MAMMALIAN TARGET OF RAPAMYCIN; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSLATION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTHRACENES; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; EUKARYOTIC INITIATION FACTOR-4G; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; RNA CAPS; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84855649801     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1252     Document Type: Article

References (27)

1. Graff JR, Konicek BW, Vincent TM, et al: Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest 117: 2638-2648, 2007. (Pubitemid 47494364)
2. Jacobson BA, Alter MD, Kratzke MG, et al: Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo. Cancer Res 66: 4256-4262, 2006.
3. Legrier ME, Yang CP, Yan HG, et al: Targeting protein translation in human non small cell lung cancer via combined MEK and mammalian target of rapamycin suppression. Cancer Res 67: 11300-11308, 2007.
4. Avdulov S, Li S, Michalek V, et al: Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 5: 553-563, 2004. (Pubitemid 38748917)
5. Mamane Y, Petroulakis E, Rong L, Yoshida K, Ler LW and Sonenberg N: eIF4E - from translation to transformation. Oncogene 23: 3172-3179, 2004. (Pubitemid 38638828)
6. Sonenberg N and Pause A: Signal transduction. Protein synthesis and oncogenesis meet again. Science 314: 428-429, 2006. (Pubitemid 44628952)
7. Armengol G, Rojo F, Castellvi J, et al: 4E-binding protein 1: a key molecular 'funnel factor' in human cancer with clinical implications. Cancer Res 67: 7551-7555, 2007.
8. Gingras AC, Gygi SP, Raught B, et al: Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev 13: 1422-1437, 1999. (Pubitemid 29270247)
9. Lawrence JC Jr, Fadden P, Haystead TA and Lin TA: PHAS proteins as mediators of the actions of insulin, growth factors and cAMP on protein synthesis and cell proliferation. Adv Enzyme Regul 37: 239-267, 1997. (Pubitemid 27371563)
10. Patel MR, Jacobson BA, De A, et al: Ras pathway activation in malignant mesothelioma. J Thorac Oncol 2: 789-795, 2007. (Pubitemid 47361018)
11. Nitta RT, Del Vecchio CA, Chu AH, Mitra SS, Godwin AK and Wong AJ: The role of the c-Jun N-terminal kinase 2-alpha-isoform in non-small cell lung carcinoma tumorigenesis. Oncogene 30: 234-244, 2011.
12. Cellurale C, Sabio G, Kennedy NJ, et al: Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation. Mol Cell Biol 31: 1565-1576, 2011.
13. Khatlani TS, Wislez M, Sun M, et al: c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells. Oncogene 26: 2658-2666, 2007. (Pubitemid 46632007)
14. Jacobson BA, De A, Kratzke MG, et al: Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma. Br J Cancer 101: 424-431, 2009.
15. Gingras AC, Kennedy SG, O'Leary MA, Sonenberg N and Hay N: 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev 12: 502-513, 1998. (Pubitemid 28101013)
16. Raivich G: c-Jun expression, activation and function in neural cell death, inflammation and repair. J Neurochem 107: 898-906, 2008.
17. Li S, Takasu T, Perlman DM, et al: Translation factor eIF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c release. J Biol Chem 278: 3015-3022, 2003. (Pubitemid 36801209)
18. Mamane Y, Petroulakis E, LeBacquer O and Sonenberg N: mTOR, translation initiation and cancer. Oncogene 25: 6416-6422, 2006. (Pubitemid 44582285)
19. Sun SY, Rosenberg LM, Wang X, et al: Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Cancer Res 65: 7052-7058, 2005. (Pubitemid 41161231)
20. Wan X, Harkavy B, Shen N, Grohar P and Helman LJ: Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 26: 1932-1940, 2007. (Pubitemid 46474636)
21. Panner A, Nakamura JL, Parsa AT, et al: mTOR-independent translational control of the extrinsic cell death pathway by RalA. Mol Cell Biol 26: 7345-7357, 2006. (Pubitemid 44547688)
22. Inoki K, Corradetti MN and Guan KL: Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 37: 19-24, 2005. (Pubitemid 40070934)
23. Bogoyevitch MA and Kobe B: Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol Mol Biol Rev 70: 1061-1095, 2006. (Pubitemid 44958264)
24. Manning AM and Davis RJ: Targeting JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discov 2: 554-565, 2003. (Pubitemid 37361747)
25. Karin M and Gallagher E: From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 57: 283-295, 2005. (Pubitemid 40904256)
26. Bain J, McLauchlan H, Elliott M and Cohen P: The specificities of protein kinase inhibitors: an update. Biochem J 371: 199-204, 2003. (Pubitemid 36458094)
27. Huang S, Shu L, Dilling MB, et al: Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). Mol Cell 11: 1491-1501, 2003. (Pubitemid 36776536)